**
In India, a staggering 50,000 lives are claimed each year due to snakebites, accounting for nearly half of all global fatalities from this often-overlooked threat. While some individuals like Devendra, a farmer who lost his leg to a snakebite, have survived, the healthcare challenges surrounding this issue remain dire. A recent report from the Global Snakebite Taskforce highlights that an overwhelming 99% of healthcare professionals face significant obstacles in administering life-saving antivenom, exacerbating an already critical situation.
The Hidden Toll of Snakebites
The harrowing reality of snakebite incidents in India paints a grim picture. Estimates suggest that between 2000 and 2019, the country may have experienced as many as 1.2 million fatalities from snakebites, averaging around 58,000 deaths annually. According to the World Health Organization (WHO), snakebite envenoming is classified as a “highest priority neglected tropical disease,” a designation reflecting the urgent need for intervention. The WHO reports that approximately 5.4 million people globally suffer snakebites each year, resulting in over 100,000 deaths.
Dr Yogesh Jain, a member of the Global Snakebite Taskforce and a practitioner in Chhattisgarh, notes that fatalities are particularly prevalent in rural areas, where agricultural workers, often from impoverished tribal communities, are most at risk. He explains that snakebites are viewed as a “poor person’s problem” in India, leading to a lack of urgency in addressing these preventable deaths.
Barriers to Effective Treatment
A recent survey conducted by the Global Snakebite Taskforce revealed alarming gaps in the healthcare system. Among 904 medical professionals in India, Brazil, Indonesia, and Nigeria—countries significantly impacted by snakebites—nearly half reported that delays in treatment frequently resulted in serious complications for patients, including amputations and long-term mobility issues. The challenges faced by healthcare workers include inadequate infrastructure, limited access to antivenom, and insufficient training in administering these crucial treatments.
The urgency of timely healthcare is further underscored by the rapid action required once a snakebite occurs. Venom can enter the bloodstream within minutes, potentially leading to life-threatening complications such as respiratory failure or organ failure. Unfortunately, many rural residents encounter barriers to timely hospitalisation, including poorly maintained roads and a lack of ambulance services. A tragic incident in Gujarat last September highlighted this issue when a pregnant woman died en route to a hospital, requiring her family to carry her for five kilometres due to inaccessible transport.
The Quest for Better Antivenom
The current antivenom available in India primarily targets the so-called “big four” snakes—the spectacled cobra, common krait, Russell’s viper, and saw-scaled viper. However, numerous other venomous species remain unaddressed. Gerry Martin, co-founder of The Liana Trust, which focuses on reducing human-snake conflict in Karnataka, emphasises the urgent need for high-quality, region-specific antivenoms. A study from the All India Institute of Medical Sciences highlighted the inadequacy of existing treatments, finding that a significant proportion of patients did not respond well to antivenom intended for the big four.
For the past five years, The Liana Trust has endeavoured to develop antidotes for other snake species, but progress has been slow and labour-intensive. Martin advocates for all states to adopt measures similar to Karnataka’s recent directive, which classifies snakebites as a notifiable disease, thus mandating reporting by healthcare professionals to improve data collection and response strategies.
A Call to Action
The launch of the National Action Plan for Prevention and Control of Snakebite Envenoming (NAPSE) in 2024 marked a significant step forward, aiming to reduce snakebite deaths by half by 2030. The plan focuses on enhancing surveillance, increasing antivenom availability, bolstering medical training, and raising public awareness. However, experts caution that the real challenge lies in the consistent implementation of these initiatives.
Dr Jain poignantly remarks, “Snakebite deaths start where political will ends.” He urges governments to ensure equitable access to health systems for all citizens, especially those from economically disadvantaged backgrounds.
Why it Matters
The snakebite crisis in India is not merely a public health issue; it reflects deeper societal inequalities and systemic failures in healthcare delivery. Addressing this crisis requires a multifaceted approach that encompasses improved medical infrastructure, community education, and government accountability. As the death toll continues to rise, it is imperative that stakeholders act decisively to protect the most vulnerable populations from this preventable tragedy.